PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Saag, Kenneth
TI  - Lesinurad Provides Additional Lowering of SUA in Gout
DP  - 2014  01
TA  - MD Conference Express
PG  - 10--10
VI  - 14
IP  - 51
4099  - http://mdc.sagepub.com/content/14/51/10.short
4100  - http://mdc.sagepub.com/content/14/51/10.full
AB  - Current management of gout is suboptimal, and patients often do not achieve serum uric acid (SUA) targets with allopurinol monotherapy. This article discusses the results of 2 replicate phase 3 studies known as Combining Lesinurad With Allopurinol in Inadequate Responders [CLEAR 1 and CLEAR 2; NCT01510158 and NCT01493531, respectively] conducted in symptomatic adults with gout.